SETDB1 and breast neoplasm: RNA-seq analyses showed that SETDB1/PELP1-regulated genes overlap, with respect to ER signaling, tamoxifen resistance, and PI3K–Akt signaling, suggesting that cytoplasmic localization of PELP1 in breast tumors may enhance SETDB1’s oncogenic functions [35].